FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint February 14, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer